DAWN — Day One Biopharmaceuticals Share News
0.000.00%
Last trade - 00:00- $2.22bn
- $1.78bn
- $158.18m
Brief: Day One Reports First Quarter 2023 Financial Results And Corporate Progress
Brief: Day One Reports Fourth Quarter And Full Year 2022 Financial Results And Corporate Progress
U.S. RESEARCH ROUNDUP-Blackline, Harmonic, Thor Industries
Brief: Day One Announces Topline Data From Pivotal Phase 2 Firefly-1 Trial Demonstrating Meaningful Responses With Tovorafenib In Recurrent Or Progressive Pediatric Low-Grade Glioma
Brief: Day One Biopharmaceuticals Inc Reports Quarterly Loss Per Share Of $0.53
Brief: Day One Announces Cooperative Research And Development Agreement With National Cancer Institute
Brief: Day One Biopharmaceuticals Inc Says Board's Size Increased To Nine Directors
Brief: Day One Appoints Garry Nicholson As Chairman Of The Board Of Directors
U.S. RESEARCH ROUNDUP-Organon & Co, Signify Health, Whitehorse Finance
U.S. RESEARCH ROUNDUP- Axon Enterprise, Berkeley Lights, Minerva Surgical
Brief: Day One Reports Second Quarter 2022 Financial Results And Corporate Progress
Brief: Day One Announces Closing Of Upsized Public Offering
U.S. RESEARCH ROUNDUP-Advent Technologies Holdings, Hyliion Holdings, Wingstop
U.S. STOCKS ON THE MOVE-Boeing, 180 Life Sciences, VectivBio Holding
U.S. STOCKS ON THE MOVE-Waterdrop, 180 Life Sciences, Tapestry
Day One Biopharma rises after upsized $150 mln stock offering
Brief: Day One Biopharmaceuticals Announces Pricing of Upsized Public Offering 10 Million Shares of Common Stock
Brief: Day One Announces Proposed Public Offering Of Common Stock
Day One Biopharma surges on promising data for childhood brain cancer drug